Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.61 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.61 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.56 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.56 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | BCL2 | P10415 | 1/20 | 0.41 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
| ▸ | BCL2L2 | Q92843 | 1/20 | 0.41 |
| ▸ | RNASEH1 | O60930 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 3/20 | 0.40 |
| ▸ | CA2 | P00918 | 3/20 | 0.40 |
| ▸ | SELL | P14151 | 1/20 | 0.40 |
| ▸ | SELP | P16109 | 1/20 | 0.40 |
| ▸ | SELE | P16581 | 1/20 | 0.40 |
| ▸ | TYR | P14679 | 3/20 | 0.39 |
| ▸ | HTT | P42858 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2754950 | 0.87 | PTGS1 (0.55) | GABRA1GABRB2TRPA1PTGS1CACNA1C | |
| SCHEMBL6346880 | 0.85 | GABRA1 (0.73) | GABRA1GABRB2TRPA1PTGS1CACNA1C | |
| SCHEMBL25505919 | 0.82 | GABRA1 (0.47) | GABRA1GABRB2TRPA1PTGS1CACNA1C | |
| SCHEMBL6943696 | 0.79 | GABRA1 (0.65) | GABRA1GABRB2TRPA1PTGS1CACNA1C | |
| SCHEMBL30467045 | 0.79 | GABRA1 (0.65) | GABRA1GABRB2TRPA1PTGS1CACNA1C | |
| SCHEMBL1487378 | 0.79 | PTGS1 (0.54) | GABRA1GABRB2TRPA1PTGS1CACNA1C | |
| SCHEMBL18778629 | 0.79 | PTGS1 (0.44) | GABRA1GABRB2TRPA1PTGS1CACNA1C | |
| SCHEMBL13581438 | 0.79 | USP2 (0.46) | GABRA1GABRB2TRPA1PTGS1CACNA1C | |
| SCHEMBL20193726 | 0.78 | SELL (0.45) | GABRA1GABRB2TRPA1PTGS1CACNA1C | |
| SCHEMBL24507824 | 0.77 | PTGS1 (0.43) | GABRA1GABRB2TRPA1PTGS1CACNA1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013092427-A2 | ANTIMICROBIAL METHOD AND COMPOSITION | UNILEVER N.V. (NL) | 2013-06-27 | — | — | WO | claimed |
| WO-2013083585-A1 | ANTIMICROBIAL COMPOSITION | UNILEVER N.V. (NL) | 2013-06-13 | — | — | WO | claimed |
| US-20230382926-A1 | COMPOUNDS AND USES THEREOF | THE UNIVERSITY OF THE WEST INDIES (TT) | 2023-11-30 | — | — | US | disclosed |
| US-8962244-B2 | Compounds for modulating RNA binding proteins and uses therefor | UNIVERSITY OF MASSACHUSETTS (US) | 2015-02-24 | — | — | US | disclosed |
| US-20130217685-A1 | COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR | UNIVERSITY OF MASSACHUSETTS (US) | 2013-08-22 | — | — | US | disclosed |
| WO-2013092427-A2 | ANTIMICROBIAL METHOD AND COMPOSITION | UNILEVER N.V. (NL) | 2013-06-27 | — | — | WO | disclosed |
| WO-2013092427-A2 | ANTIMICROBIAL METHOD AND COMPOSITION | UNILEVER N.V. (NL) | 2013-06-27 | — | — | WO | disclosed |
| WO-2013083585-A1 | ANTIMICROBIAL COMPOSITION | UNILEVER N.V. (NL) | 2013-06-13 | — | — | WO | disclosed |
| WO-2013083585-A1 | ANTIMICROBIAL COMPOSITION | UNILEVER N.V. (NL) | 2013-06-13 | — | — | WO | disclosed |
| US-8377639-B2 | Compounds for modulating RNA binding proteins and uses therefor | UNIVERSITY OF MASSACHUSETTS (US) | 2013-02-19 | — | — | US | disclosed |
| US-20110065704-A1 | COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-03-17 | — | — | US | disclosed |
| CN-101313021-A | Radiation absorbing compositions, methods and articles made by applying such compositions | MILLIKEN & CO (US) | 2008-11-26 | — | — | CN | disclosed |
| US-6242514-B1 | CYCLIC PHOSPHATE OR PHOSPHONATE; HEAT AND OXIDATION STABILIZER ESPECIALLY FOR OLEFIN POLYMERS AND ENGINEERING THERMOPLASTICS | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 2001-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130217685-A1 | COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR | TIA1, ZFP3, RBM3 | GABRA1 1857/4885GABRB2 2445/4885TRPA1 754/4885 |
| US-20230382926-A1 | COMPOUNDS AND USES THEREOF | CFTR, CCL11, CEL | GABRA1 2548/4885GABRB2 3275/4885TRPA1 448/4885 |
| US-20110065704-A1 | COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR | TIA1, ZFP3, RBM3 | GABRA1 1857/4885GABRB2 2445/4885TRPA1 754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.